Together, these earlier reports indicate that the presence or absence of ACPA could significantly shape the most effective treatment strategy for RA, underscoring the importance of a patient-centric approach to RA treatment by considering each patient’s ACPA status. This evidence concerns the gene PRTN3 and rheumatoid arthritis.